Canada· CA-DIN-02543338
SIBBORAN
A landiolol product containing landiolol hydrochloride, registered in Canada by TRIMEDIC THERAPEUTICS INC.. The same ATC class is registered in 15 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Landiolol is registered in 15 of 19 countries.
Countries holding a registration under ATC C07AB14 (landiolol), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 9 of them publish a price we can compare per daily dose
Landiolol · ATC C07AB14
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- LANDIOLOL HYDROCHLORIDE
- Manufacturer
- TRIMEDIC THERAPEUTICS INC.
- Country
- Canada (CA)
- ATC code
- C07AB14
- ATC class
- Landiolol
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Landiolol in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- Japanランジオロール塩酸塩小野薬品工業
- CzechiaRAPIBLOCAmomed Pharma GmbH, Vídeň
- NetherlandsLandiolol Hydrochloride Orpha-Devel 300 mg poeder voor oplossing voor infusieOrpha Devel Handels-und Vertriebs GmbH
- United StatesRAPIBLYKAOP Orphan Pharmaceuticals GmbH
- FranceRAPIBLOC 20 mg/2 ml, solution à diluer injectableAMOMED PHARMA (AUTRICHE)
- SwedenRapibloc 10 mg/ml Koncentrat till injektionsvätska, lösningAmomed Pharma GmbH
- NorwayRaplocAmomed Pharma GmbH
- PolandRunrapiqAmomed Pharma GmbH
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Rapibloc
- Belgium · Runrapiq
- Bulgaria · Рапиблок
- Cyprus · Rapibloc
- Czechia · Rapibloc
- Germany · Rapibloc
- Denmark · Rapibloc
- Estonia · Raploc
- Spain · Rapibloc
- Finland · Rapibloc
- France · Rapibloc
- Greece · Rapibloc
- Croatia · Rapibloc
- Hungary · Rapibloc
- Ireland · Rapibloc
- Italy · Landiobloc
- Lithuania · Raploc
- Latvia · Raploc
- Netherlands · Landiolol Hydrochloride Orpha-Devel, Rapibloc
- Norway · Raploc
- Poland · Runrapiq
- Portugal · Rapibloc
- Romania · Rapibloc
- Sweden · Rapibloc
- Slovenia · Rapibloc
- Slovakia · Rapibloc
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f814cda9-6fe8-47f8-9b39-76356777454e GET /v1/drugs/f814cda9-6fe8-47f8-9b39-76356777454e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02543338",
"form": "POWDER FOR SOLUTION",
"class": "Human",
"routes": [
"INTRAVENOUS"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "C07AB14",
"schedule": [
"Prescription"
],
"drug_code": "103179",
"strengths": [
"300 MG"
],
"ahfs_class": null,
"substances": [
"LANDIOLOL HYDROCHLORIDE"
],
"product_categorization": null
}See everything about landiolol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.